跳到正文

Logos Global Management LP 13F 持仓 · 2026年Q2

Logos Global Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 68 只证券,申报市值合计 23.23 亿美元。前几大持仓:ERAS(9.58%)、ABVX(5.87%)、RVMD(5.64%)。本季前 25 大持仓中:新建仓 6 只、增持 13 只、减持 5 只。

排名代码公司市值占组合股数变动
1ERASERASCA INC$222.6M9.58%12.2M增持
2ABVXABIVAX SA$136.5M5.87%1.0M增持
3RVMDREVOLUTION MEDICINES INC$131.1M5.64%700,000减持
4IDYAIDEAYA BIOSCIENCES INC$111.8M4.81%3.0M减持
5BNTXBIONTECH SE$94.4M4.07%1.0M新建仓
6VERAVERA THERAPEUTICS INC$94.4M4.06%2.2M新建仓
7TNGXTANGO THERAPEUTICS INC$89.1M3.84%2.9M减持
8PRAXPRAXIS PRECISION MEDICINES I$87.0M3.75%260,000减持
9CLDXCELLDEX THERAPEUTICS INC NEW$78.1M3.36%2.1M增持
10DNTHDIANTHUS THERAPEUTICS INC$78.0M3.36%800,000增持
11CGONCG ONCOLOGY INC$71.0M3.06%1.0M增持
12IRONDISC MEDICINE INC$64.0M2.76%875,000增持
13MAZEMAZE THERAPEUTICS INC$57.7M2.49%1.9M增持
14DYNDYNE THERAPEUTICS INC$56.6M2.44%2.5M增持
15MLTXMOONLAKE IMMUNOTHERAPEUTICS$52.1M2.24%2.7M增持
16OCULOCULAR THERAPEUTIX INC$52.0M2.24%5.3M增持
17DSGNDESIGN THERAPEUTICS INC$43.4M1.87%3.0M增持
18OLMAOLEMA PHARMACEUTICALS INC$40.1M1.73%3.2M持平
19BLTEBELITE BIO INC$38.5M1.66%250,000新建仓
20ACHVACHIEVE LIFE SCIENCE INC$35.4M1.53%5.4M新建仓
21TRVITREVI THERAPEUTICS INC$35.1M1.51%1.9M减持
22AVBPARRIVENT BIOPHARMA INC$34.7M1.50%1.0M增持
23COGTCOGENT BIOSCIENCES INC$34.8M1.50%900,000新建仓
24CBIOCRESCENT BIOPHARMA INC.$34.2M1.47%1.9M增持
25CMPSCOMPASS PATHWAYS PLC$31.8M1.37%2.2M新建仓

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR